Trademarkia Logo

Australia

AU$
XENLETA
Protected: Registered/protected

Last updated on 30 Sept 2021

Owner Info

Nabriva Therapeutics US, Inc.

414 Commerce Drive, Suite 120

Fort Washington PA 19034, UNITED STATES OF AMERICA

Serial Number

2067194 filed on 31 Dec 2019

Correspondent

Anne H. Peck

Cooley LLP,,

1299 Pennsylvania Avenue NW,,

UNITED STATES OF AMERICA

XENLETA

Classification Information


Class [005]
Pharmaceutical preparations for treating respiratory illnesses; antibiotics; anti-infectives; pharmaceutical preparations for the treatment of pneumon Read More

Mark Details


Serial Number

2067194

Registered On

31 Dec 2019

Renewal On

31 Dec 2029

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

8 Jul 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Sept 2021Amendment to Amend Owner Requested
8th Jul 2021Amendment to International Registration Contact Requested
28th Jul 2020International Registration in Australia Protected correspondence sent
27th Jul 2020IP Right Registration Published
27th Jul 2020Status change to Registered/Protected
21st May 2020Application Accepted correspondence sent
20th May 2020IP Right has been Examined
20th May 2020IP Right Acceptance Published
20th May 2020Status change to Accepted
6th Feb 2020Examination expedited